Neurologic syndromes related to anti-GAD65: Clinical and serologic response to treatment

OBJECTIVE: Antibodies against glutamic acid decarboxylase 65 (anti-GAD65) are associated with a number of neurologic syndromes. However, their pathogenic role is controversial. Our objective was to describe clinical and paraclinical characteristics of anti-GAD65 patients and analyze their response t...

Descripción completa

Detalles Bibliográficos
Autores principales: Muñoz-Lopetegi, Amaia, de Bruijn, Marienke A.A.M., Boukhrissi, Sanae, Bastiaansen, Anna E.M., Nagtzaam, Mariska M.P., Hulsenboom, Esther S.P., Boon, Agnita J.W., Neuteboom, Rinze F., de Vries, Juna M., Sillevis Smitt, Peter A.E., Schreurs, Marco W.J., Titulaer, Maarten J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136051/
https://www.ncbi.nlm.nih.gov/pubmed/32123047
http://dx.doi.org/10.1212/NXI.0000000000000696

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136051/
https://www.ncbi.nlm.nih.gov/pubmed/32123047
http://dx.doi.org/10.1212/NXI.0000000000000696

Ejemplares similares